Fundz
Real-time · AI · Cross-signal

DelveInsight just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on DelveInsight, plus every contract, funding round, and exec hire that follows, each with verified, ICP-ranked contacts.

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Get the full Deep Dive on DelveInsight — free.

We'll email your report. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

▶
Watch the 2-minute tour · with sound

DelveInsight Partners with Large Pharmaceutical Company for Evaluating CDMO Capabilities

Jan 02, 2025•over 1 year ago

Contract Type

partnership

Las VegasBiotechnologyPharmaceuticalConsulting

Description

DelveInsight partnered with a large pharmaceutical company to assess and benchmark contract development and manufacturing organizations (CDMOs) for outsourcing capabilities in API and FD development. They delivered an in-depth report enabling the client to make informed decisions for optimal outsourcing efficiency.

Company Information

Company

DelveInsight

Location

Las Vegas, Nevada, United States

About

DelveInsight is a leading provider of pharma competitive intelligence and consulting solutions, specializing in the rare diseases domain. The company has published over 350 epidemiology-based market reports and leverages a network of Key Opinion Leaders to provide insights into the rare disease market. Their services encompass R&D, market access, and commercialization strategies tailored for the unique challenges of rare conditions. DelveInsight aims to empower pharmaceutical and biotech firms to navigate the complexities of the orphan disease market effectively.

Predictive Intelligence
Strategic

ML-powered predictions for DelveInsight's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.